Bortezomib Injection

Get a Price/Quote

Bortezomib Injection Specification

Salt Composition
Bortezomib 2 mg/vial

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Dosage Form
Lyophilized Powder for Injection

Enzyme Types
Proteasome Inhibitor (not an enzyme but acts on enzyme pathways)

Feature
Sterile, Single-use Vial

Ingredients
Bortezomib, Mannitol (as excipient)

Application
Anticancer Therapy

Ph Level
pH 4.0-5.0 after reconstitution

Physical Color/Texture
White to Off-white Lyophilized Powder

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits 26S Proteasome activity

Storage Instructions
Store at 2C to 8C (Refrigerated)

Shelf Life
2 years

Bortezomib Injection Trade Information

FOB Port
All Indian Port

Payment Terms
Western Union, Paypal, Telegraphic Transfer (T/T), Cash in Advance (CID)

Delivery Time
7 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Standard Packing

Main Export Market(s)
Australia, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia, North America

Certifications
ISO, GMP, WHO

About Bortezomib Injection

Product Name : Bortezomib Injection
Trade Name : Bortecad, Bortenat
Available Strength : 2mg, 3.5mg
Packing : Sterile Single Dose vial (Lyophilized)
Pack Insert/Leaflet : Yes
Therapeutic use : Anti Cancer
Production Capacity : 10,000 inj./Month

What Is Bortezomib?
Bortezomib contains the active substance bortezomib, the so-called proteasome inhibitor which plays important role in controlling the growth and function of the cell.

Bortezomib Injection Uses
This medication is used for the treatment of

Multiple Myeloma
Mantle Cell Lymphoma

How Does Bortezomib Injection Works?
It works by helping the breakdown down proteins that the cell doesnt need and blocks the proteasomes so the protein builds up inside the cell which causes cell death.

Available Strength: